{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:51:59Z","timestamp":1772643119924,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A2B2002923"],"award-info":[{"award-number":["2020R1A2B2002923"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC2211670-1"],"award-info":[{"award-number":["NCC2211670-1"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC2211670-1"],"award-info":[{"award-number":["NCC2211670-1"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003645","name":"National Cancer Center","doi-asserted-by":"publisher","award":["NCC2211670-1"],"award-info":[{"award-number":["NCC2211670-1"]}],"id":[{"id":"10.13039\/501100003645","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2023,6,2]]},"DOI":"10.1038\/s41388-023-02692-9","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T03:14:42Z","timestamp":1681355682000},"page":"1832-1842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel thrombospondin-1 transcript exhibits distinctive expression and activity in thyroid tumorigenesis"],"prefix":"10.1038","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3018-4539","authenticated-orcid":false,"given":"Yukyung","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2674-2227","authenticated-orcid":false,"given":"Ilju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjin","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3362-320X","authenticated-orcid":false,"given":"Jaehak","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7517-7033","authenticated-orcid":false,"given":"Pattawika","family":"Lertpatipanpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Hwan","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuh-Seog","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jungirl","family":"Seok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junsun","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7866-7778","authenticated-orcid":false,"given":"Seung Joon","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"2692_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. Ca-Cancer J Clin. 2022;72:7\u201333.","journal-title":"Ca-Cancer J Clin"},{"key":"2692_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4143\/crt.2022.128","volume":"54","author":"MJ Kang","year":"2022","unstructured":"Kang MJ, Won YJ, Lee JJ, Jung KW, Kim HJ, Kong HJ, et al. Cancer Statistics in Korea: Incidence, mortality, survival, and prevalence in 2019. Cancer Res Treat. 2022;54:330\u201344.","journal-title":"Cancer Res Treat"},{"key":"2692_CR3","first-page":"9937742","volume":"2021","author":"RX Li","year":"2021","unstructured":"Li RX, Hao JP, Zhu Z, Qiao XD, Wang L, Zhou ZB. Correlation between US-FNAC with BRAF V600E Mutation Analysis and Central Neck Lymph Node Metastasis in cN0 Papillary Thyroid Cancer. Biomed Res Int. 2021;2021:9937742.","journal-title":"Biomed Res Int"},{"key":"2692_CR4","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1089\/thy.2014.0140","volume":"24","author":"RG Yoon","year":"2014","unstructured":"Yoon RG, Baek JH, Lee JH, Choi YJ, Hong MJ, Song DE, et al. Diagnosis of thyroid follicular neoplasm: fine-needle aspiration versus core-needle biopsy. Thyroid. 2014;24:1612\u20137.","journal-title":"Thyroid"},{"key":"2692_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.5603\/EP.2016.0003","volume":"67","author":"A Stanek-Widera","year":"2016","unstructured":"Stanek-Widera A, Biskup-Fruzynska M, Zembala-Nozynska E, Poltorak S, Snietura M, Lange D. Suspicious for follicular neoplasm or follicular neoplasm? The dilemma of a pathologist and a surgeon. Endokrynol Pol. 2016;67:17\u201322.","journal-title":"Endokrynol Pol"},{"key":"2692_CR6","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.3390\/cancers13123022","volume":"13","author":"Y Hong","year":"2021","unstructured":"Hong Y, Lee J, Moon H, Ryu CH, Seok J, Jung YS, et al. Quercetin induces anticancer activity by upregulating Pro-NAG-1\/GDF15 in differentiated thyroid cancer cells. Cancers (Basel). 2021;13:3022.","journal-title":"Cancers (Basel)"},{"key":"2692_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/328170a0","volume":"328","author":"A Fusco","year":"1987","unstructured":"Fusco A, Grieco M, Santoro M, Berlingieri M, Pilotti S, Pierotti M, et al. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature. 1987;328:170\u20132.","journal-title":"Nature"},{"key":"2692_CR8","doi-asserted-by":"publisher","first-page":"6646","DOI":"10.1038\/sj.onc.1208822","volume":"24","author":"TJ Giordano","year":"2005","unstructured":"Giordano TJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, et al. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET\/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene. 2005;24:6646\u201356.","journal-title":"Oncogene"},{"key":"2692_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrendo.2014.115","volume":"10","author":"P Raman","year":"2014","unstructured":"Raman P, Koenig RJ. Pax-8-PPAR-\u03b3 fusion protein in thyroid carcinoma. Nat Rev Endocrinol. 2014;10:616\u201323.","journal-title":"Nat Rev Endocrinol"},{"key":"2692_CR10","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1172\/JCI115472","volume":"88","author":"MA Herrmann","year":"1991","unstructured":"Herrmann MA, Hay ID, Bartelt DH Jr, Ritland SR, Dahl RJ, Grant CS, et al. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest. 1991;88:1596\u2013604.","journal-title":"J Clin Invest"},{"key":"2692_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1530\/EJE-11-0499","volume":"165","author":"V Marotta","year":"2011","unstructured":"Marotta V, Guerra A, Sapio MR, Vitale M. RET\/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint. Eur J Endocrinol. 2011;165:499\u2013507.","journal-title":"Eur J Endocrinol"},{"key":"2692_CR12","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/embor.2008.189","volume":"9","author":"AR Grosso","year":"2008","unstructured":"Grosso AR, Martins S, Carmo-Fonseca M. The emerging role of splicing factors in cancer. EMBO Rep. 2008;9:1087\u201393.","journal-title":"EMBO Rep"},{"key":"2692_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nbt964","volume":"22","author":"MA Garcia-Blanco","year":"2004","unstructured":"Garcia-Blanco MA, Baraniak AP, Lasda EL. Alternative splicing in disease and therapy. Nat Biotechnol. 2004;22:535\u201346.","journal-title":"Nat Biotechnol"},{"key":"2692_CR14","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1038\/sj.onc.1208603","volume":"24","author":"D Lazzereschi","year":"2005","unstructured":"Lazzereschi D, Nardi F, Turco A, Ottini L, D\u2019Amico C, Mariani-Costantini R, et al. A complex pattern of mutations and abnormal splicing of Smad4 is present in thyroid tumours. Oncogene. 2005;24:5344\u201354.","journal-title":"Oncogene"},{"key":"2692_CR15","doi-asserted-by":"publisher","first-page":"84546","DOI":"10.18632\/oncotarget.19165","volume":"8","author":"T Huang","year":"2017","unstructured":"Huang T, Sun L, Yuan X, Qiu H. Thrombospondin-1 is a multifaceted player in tumor progression. Oncotarget. 2017;8:84546\u201358.","journal-title":"Oncotarget"},{"key":"2692_CR16","doi-asserted-by":"publisher","first-page":"121185","DOI":"10.1016\/j.biomaterials.2021.121185","volume":"279","author":"S Patwardhan","year":"2021","unstructured":"Patwardhan S, Mahadik P, Shetty O, Sen S. ECM stiffness-tuned exosomes drive breast cancer motility through thrombospondin-1. Biomaterials. 2021;279:121185.","journal-title":"Biomaterials"},{"key":"2692_CR17","doi-asserted-by":"publisher","first-page":"656078","DOI":"10.3389\/fonc.2021.656078","volume":"11","author":"DP Mo","year":"2021","unstructured":"Mo DP, He F, Zheng JY, Chen HH, Tang L, Yan F. tRNA-Derived Fragment tRF-17-79MP9PP attenuates cell invasion and migration via THBS1\/TGF-beta 1\/Smad3 Axis in breast cancer. Front Oncol. 2021;11:656078.","journal-title":"Front Oncol"},{"key":"2692_CR18","doi-asserted-by":"publisher","first-page":"e10692","DOI":"10.1590\/1414-431x202010692","volume":"54","author":"JW Xiao","year":"2021","unstructured":"Xiao JW, Zhang Y, Tang Y, Dai HF, OuYang Y, Li CC, et al. hsa-miR-4443 inhibits myocardial fibroblast proliferation by targeting THBS1 to regulate TGF-beta 1\/alpha-SMA\/collagen signaling in atrial fibrillation. Braz J Med Biol Res. 2021;54:e10692.","journal-title":"Braz J Med Biol Res"},{"key":"2692_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1139\/bcb-2018-0302","volume":"97","author":"Q Yin","year":"2019","unstructured":"Yin Q, Wang PP, Peng R, Zhou H. MiR-19a enhances cell proliferation, migration, and invasiveness through enhancing lymphangiogenesis by targeting thrombospondin-1 in colorectal cancer. Biochem Cell Biol. 2019;97:731\u20139.","journal-title":"Biochem Cell Biol"},{"key":"2692_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fendo.2013.00189","volume":"4","author":"M Duquette","year":"2013","unstructured":"Duquette M, Sadow PM, Lawler J, Nucera C. Thrombospondin-1 Silencing down-regulates integrin expression levels in human anaplastic thyroid cancer cells with BRAF(V600E): New insights in the host tissue adaptation and homeostasis of tumor microenvironment. Front Endocrinol (Lausanne). 2013;4:189.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2692_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.yexcr.2004.10.026","volume":"304","author":"M Soula-Rothhut","year":"2005","unstructured":"Soula-Rothhut M, Coissard C, Sartelet H, Boudot C, Bellon G, Martiny L, et al. The tumor suppressor PTEN inhibits EGF-induced TSP-1 and TIMP-1 expression in FTC-133 thyroid carcinoma cells. Exp Cell Res. 2005;304:187\u2013201.","journal-title":"Exp Cell Res"},{"key":"2692_CR22","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.bbamcr.2006.08.001","volume":"1763","author":"GM Rath","year":"2006","unstructured":"Rath GM, Schneider C, Dedieu S, Rothhut B, Soula-Rothhut M, Ghoneim C, et al. The C-terminal CD47\/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochim Biophys Acta. 2006;1763:1125\u201334.","journal-title":"Biochim Biophys Acta"},{"key":"2692_CR23","doi-asserted-by":"publisher","first-page":"10649","DOI":"10.1073\/pnas.1004934107","volume":"107","author":"C Nucera","year":"2010","unstructured":"Nucera C, Porrello A, Antonello ZA, Mekel M, Nehs MA, Giordano TJ, et al. B-RafV600 and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci. 2010;107:10649.","journal-title":"Proc Natl Acad Sci"},{"key":"2692_CR24","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/neuonc\/noab212","volume":"24","author":"JV Joseph","year":"2022","unstructured":"Joseph JV, Magaut CR, Storevik S, Geraldo LH, Mathivet T, Latif MA, et al. TGF-beta promotes microtube formation in glioblastoma through thrombospondin 1. Neuro Oncol. 2022;24:541\u201353.","journal-title":"Neuro Oncol"},{"key":"2692_CR25","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.2174\/187152012803833026","volume":"12","author":"H Wang","year":"2012","unstructured":"Wang H, Khor TO, Shu L, Su Z-Y, Fuentes F, Lee J-H, et al. Plants vs. cancer: A review on natural phytochemicals in preventing and treating cancers and their druggability. Anticancer Agents Med Chem. 2012;12:1281\u2013305.","journal-title":"Anticancer Agents Med Chem"},{"key":"2692_CR26","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3390\/cells10040858","volume":"10","author":"J Oh","year":"2021","unstructured":"Oh J, Pradella D, Shao C, Li H, Choi N, Ha J, et al. Widespread alternative splicing changes in metastatic breast cancer cells. Cells. 2021;10:858.","journal-title":"Cells"},{"key":"2692_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13046-021-01978-8","volume":"40","author":"JX Du","year":"2021","unstructured":"Du JX, Luo YH, Zhang SJ, Wang B, Chen C, Zhu GQ, et al. Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1. J Exp Clin Cancer Res. 2021;40:171.","journal-title":"J Exp Clin Cancer Res"},{"key":"2692_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26624-w","volume":"8","author":"R Murayama","year":"2018","unstructured":"Murayama R, Kimura-Asami M, Togo-Ohno M, Yamasaki-Kato Y, Naruse TK, Yamamoto T, et al. Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization. Sci Rep. 2018;8:8970.","journal-title":"Sci Rep"},{"key":"2692_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15134","volume":"8","author":"JJL Wong","year":"2017","unstructured":"Wong JJL, Gao DD, Nguyen TV, Kwok CT, van Geldermalsen M, Middleton R, et al. Intron retention is regulated by altered MeCP2-mediated splicing factor recruitment. Nat Commun. 2017;8:15134.","journal-title":"Nat Commun"},{"key":"2692_CR30","first-page":"1048","volume":"1861","author":"B Chatterjee","year":"2018","unstructured":"Chatterjee B, Lin MH, Chen CC, Peng KL, Wu MS, Tseng MC, et al. DNA Demethylation by DNMT3A and DNMT3B in vitro and of Methylated Episomal DNA in Transiently Transfected Cells. Bba-Gene Regul Mech. 2018;1861:1048\u201361.","journal-title":"Bba-Gene Regul Mech"},{"key":"2692_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1158\/0008-5472.CAN-15-0484","volume":"76","author":"B Kaczkowski","year":"2016","unstructured":"Kaczkowski B, Tanaka Y, Kawaji H, Sandelin A, Andersson R, Itoh M, et al. Transcriptome analysis of recurrently deregulated genes across multiple cancers identifies new pan-cancer biomarkers. Cancer Res. 2016;76:216\u201326.","journal-title":"Cancer Res"},{"key":"2692_CR32","doi-asserted-by":"crossref","first-page":"T301","DOI":"10.1530\/ERC-13-0165","volume":"21","author":"SJ Hsiao","year":"2014","unstructured":"Hsiao SJ, Nikiforov YE. Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer. 2014;21:T301\u2013T313.","journal-title":"Endocr Relat Cancer"},{"key":"2692_CR33","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1096\/fj.05-3712fje","volume":"19","author":"OI Stenina","year":"2005","unstructured":"Stenina OI, Ustinov V, Krukovets I, Marinic T, Topol EJ, Plow EF. Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites. The FASEB Journal. 2005;19:1893\u20135.","journal-title":"The FASEB Journal"},{"key":"2692_CR34","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1006\/bbrc.1999.0812","volume":"259","author":"KW Adolph","year":"1999","unstructured":"Adolph KW. Detection of exon skipping and retained introns in transcription of the human Thrombospondin 2 Gene. Biochem Biophys Res Commun. 1999;259:527\u201332.","journal-title":"Biochem Biophys Res Commun"},{"key":"2692_CR35","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ajhg.2008.03.013","volume":"82","author":"Y Hirose","year":"2008","unstructured":"Hirose Y, Chiba K, Karasugi T, Nakajima M, Kawaguchi Y, Mikami Y, et al. A functional polymorphism in THBS2 that affects alternative splicing and MMP binding is associated with lumbar-disc herniation. Am J Hum Genet. 2008;82:1122\u20139.","journal-title":"Am J Hum Genet"},{"key":"2692_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1158\/0008-5472.CAN-07-2632","volume":"68","author":"JH Lee","year":"2008","unstructured":"Lee JH, Horak CE, Khanna C, Meng Z, Yu LR, Veenstra TD, et al. Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility. Cancer Res. 2008;68:639\u201344.","journal-title":"Cancer Res"},{"key":"2692_CR37","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/mc.22386","volume":"55","author":"G Silva","year":"2016","unstructured":"Silva G, Marins M, Fachin AL, Lee SH, Baek SJ. Anti-cancer activity of trans-chalcone in osteosarcoma: Involvement of Sp1 and p53. Mol Carcinog. 2016;55:1438\u201348.","journal-title":"Mol Carcinog"},{"key":"2692_CR38","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3390\/molecules23082018","volume":"23","author":"TT Komoto","year":"2018","unstructured":"Komoto TT, Bernardes TM, Mesquita TB, Bortolotto LFB, Silva G, Bitencourt TA, et al. Chalcones repressed the AURKA and MDR proteins involved in metastasis and multiple drug resistance in breast cancer cell lines. Molecules. 2018;23:2018.","journal-title":"Molecules"},{"key":"2692_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1101\/gad.11.3.334","volume":"11","author":"SH Xiao","year":"1997","unstructured":"Xiao SH, Manley JL. Phosphorylation of the ASF\/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev. 1997;11:334\u201344.","journal-title":"Genes Dev"},{"key":"2692_CR40","doi-asserted-by":"publisher","first-page":"5996","DOI":"10.1128\/MCB.17.10.5996","volume":"17","author":"PI Duncan","year":"1997","unstructured":"Duncan PI, Stojdl DF, Marius RM, Bell JC. In vivo regulation of alternative pre-mRNA splicing by the Clk1 protein kinase. Mol Cell Biol. 1997;17:5996\u20136001.","journal-title":"Mol Cell Biol"},{"key":"2692_CR41","first-page":"1456","volume":"3","author":"W Cao","year":"1997","unstructured":"Cao W, Jamison SF, Garcia-Blanco MA. Both phosphorylation and dephosphorylation of ASF\/SF2 are required for pre-mRNA splicing in vitro. RNA. 1997;3:1456\u201367.","journal-title":"RNA"},{"key":"2692_CR42","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nsmb.1415","volume":"15","author":"R Mathew","year":"2008","unstructured":"Mathew R, Hartmuth K, Mohlmann S, Urlaub H, Ficner R, Luhrmann R. Phosphorylation of human PRP28 by SRPK2 is required for integration of the U4\/U6-U5 tri-snRNP into the spliceosome. Nat Struct Mol Biol. 2008;15:435\u201343.","journal-title":"Nat Struct Mol Biol"},{"key":"2692_CR43","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.molcel.2007.12.017","volume":"29","author":"JC Ngo","year":"2008","unstructured":"Ngo JC, Giang K, Chakrabarti S, Ma CT, Huynh N, Hagopian JC, et al. A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1. Mol Cell. 2008;29:563\u201376.","journal-title":"Mol Cell"},{"key":"2692_CR44","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1101\/gad.1752109","volume":"23","author":"XY Zhong","year":"2009","unstructured":"Zhong XY, Ding JH, Adams JA, Ghosh G, Fu XD. Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev. 2009;23:482\u201395.","journal-title":"Genes Dev"},{"key":"2692_CR45","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1210\/en.2008-0818","volume":"150","author":"K Jiang","year":"2009","unstructured":"Jiang K, Patel NA, Watson JE, Apostolatos H, Kleiman E, Hanson O, et al. Akt2 regulation of Cdc2-like kinases (Clk\/Sty), serine\/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCbetaII messenger ribonucleic acid. Endocrinology. 2009;150:2087\u201397.","journal-title":"Endocrinology"},{"key":"2692_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2174\/138920208786847971","volume":"9","author":"C Ghigna","year":"2008","unstructured":"Ghigna C, Valacca C, Biamonti G. Alternative splicing and tumor progression. Curr Genomics. 2008;9:556\u201370.","journal-title":"Curr Genomics"},{"key":"2692_CR47","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/sj.ejhg.5200334","volume":"7","author":"T Timmer","year":"1999","unstructured":"Timmer T, Terpstra P, van den Berg A, Veldhuis PM, Ter Elst A, Voutsinas G, et al. A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3. Eur J Human Genet.: EJHG. 1999;7:478\u201386.","journal-title":"Eur J Human Genet.: EJHG"},{"key":"2692_CR48","doi-asserted-by":"publisher","first-page":"101042831769454","DOI":"10.1177\/1010428317694547","volume":"39","author":"T Kobayashi","year":"2017","unstructured":"Kobayashi T, Ishida J, Shimizu Y, Kawakami H, Suda G, Muranaka T, et al. Decreased RNA-binding motif 5 expression is associated with tumor progression in gastric cancer. Tumor Biol. 2017;39:1010428317694547.","journal-title":"Tumor Biol"},{"key":"2692_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ijc.25345","volume":"128","author":"T Kobayashi","year":"2011","unstructured":"Kobayashi T, Ishida J, Musashi M, Ota S, Yoshida T, Shimizu Y, et al. p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5. Int J Cancer. 2011;128:304\u201318.","journal-title":"Int J Cancer"},{"key":"2692_CR50","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/jcb.21134","volume":"100","author":"ND Rintala-Maki","year":"2007","unstructured":"Rintala-Maki ND, Goard CA, Langdon CE, Wall VE, Traulsen KE, Morin CD, et al. Expression of RBM5-related factors in primary breast tissue. J Cell Biochem. 2007;100:1440\u201358.","journal-title":"J Cell Biochem"},{"key":"2692_CR51","doi-asserted-by":"publisher","first-page":"15027","DOI":"10.1038\/s41598-021-94581-y","volume":"11","author":"P Lertpatipanpong","year":"2021","unstructured":"Lertpatipanpong P, Lee J, Kim I, Eling T, Oh SY, Seong JK, et al. The anti-diabetic effects of NAG-1\/GDF15 on HFD\/STZ-induced mice. Sci Rep-UK. 2021;11:15027.","journal-title":"Sci Rep-UK"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02692-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02692-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02692-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T05:03:51Z","timestamp":1685682231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-023-02692-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":51,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2023,6,2]]}},"alternative-id":["2692"],"URL":"https:\/\/doi.org\/10.1038\/s41388-023-02692-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2156656\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"11 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of the National Cancer Center (NCC-2014-0003), mouse experiments were approved by the Institutional Animal Care and Use Committee of Seoul National University (SNU-210511-2-1), and all experiments were conducted in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}